Correlation Between Purple Biotech and B Communications

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Purple Biotech and B Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and B Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Purple Biotech and B Communications, you can compare the effects of market volatilities on Purple Biotech and B Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of B Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and B Communications.

Diversification Opportunities for Purple Biotech and B Communications

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Purple and BCOM is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and B Communications in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on B Communications and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with B Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of B Communications has no effect on the direction of Purple Biotech i.e., Purple Biotech and B Communications go up and down completely randomly.

Pair Corralation between Purple Biotech and B Communications

Assuming the 90 days trading horizon Purple Biotech is expected to generate 9.45 times more return on investment than B Communications. However, Purple Biotech is 9.45 times more volatile than B Communications. It trades about 0.15 of its potential returns per unit of risk. B Communications is currently generating about 0.36 per unit of risk. If you would invest  540.00  in Purple Biotech on September 12, 2024 and sell it today you would earn a total of  200.00  from holding Purple Biotech or generate 37.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Purple Biotech  vs.  B Communications

 Performance 
       Timeline  
Purple Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Purple Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
B Communications 

Risk-Adjusted Performance

29 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in B Communications are ranked lower than 29 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, B Communications sustained solid returns over the last few months and may actually be approaching a breakup point.

Purple Biotech and B Communications Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Purple Biotech and B Communications

The main advantage of trading using opposite Purple Biotech and B Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, B Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in B Communications will offset losses from the drop in B Communications' long position.
The idea behind Purple Biotech and B Communications pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Transaction History
View history of all your transactions and understand their impact on performance